I hope you have seen this...
Harvest One is a holding company that owns Canadian ACMPR licensed producer United Greeneries and Swiss medical cannabis brand Satipharm. United Greeneries received its cultivation license in June 2016 and is focused on expanding the capacity at it Duncan Facility from about 1000kg per year to about 50,000kg per year to serve both the medical and recreational markets. The company, which is targeting production capacity of 8500kg by the end of 2017, also owns a 62K sq. ft. facility on over 18 acres in Lucky Lake, Saskatchewan that has submitted an ACMPR application. The company closed a $25mm financing transaction in February to help fund its capacity expansion.
Satipharm, which is generating revenue, focuses on oral delivery technologies. It has been producing Gelpell ® Microgel Capsules, a pharmaceutical grade product with GMP production, since May 2015. The company is focusing initially on Germany and Poland and will be entering other EU countries this year. Satipharm plans to export Gelpell ® Microgel products into the Canadian ACMPR market and the Australian market and also plans to license or introduce products into regulated cannabis markets internationally.
Featured Video
A peak into United Greeneries’ flagship facility on Vancouver Island in Canada. The facility was the 30th operation that got licensed under the Canadian MMPR (now ACMPR) in June 2016 and started growing operations in December 2016. There are currently 33 different genetic varieties of cannabis in production, the first harvest is expected in March 2017.
TW
